No Monkeying Around: Clonal Tracking of Stem Cells and Progenitors in the Macaque  by Dykstra, Brad & Bystrykh, Leonid V.
Cell Stem Cell
PreviewsNo Monkeying Around: Clonal Tracking
of Stem Cells and Progenitors in the MacaqueBrad Dykstra1,* and Leonid V. Bystrykh2,*
1Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston MA 02115, USA
2Laboratory of Ageing Biology and Stem Cells, European Research Institute for Biology of Ageing, University Medical Center Groningen,
University of Groningen, 9700 AD, Groningen, The Netherlands
*Correspondence: bdykstra@partners.org (B.D.), l.bystrykh@umcg.nl (L.V.B.)
http://dx.doi.org/10.1016/j.stem.2014.03.006
Clonal tracking of hematopoietic stem and progenitor cells (HSPCs) has proven valuable for studying their
behavior in murine recipients. Now in Cell Stem Cell, Kim et al. (2014) and Wu et al. (2014) extend these
analyses to nonhuman primates, providing insights into dynamics of HSPC expansion and lineage commit-
ment following autologous transplantation.Hematopoietic stem cells (HSCs) are
remarkable in their ability to ultimately
produce billions of blood cells a day for
a lifetime, without exhaustion. Several de-
cades ago, transplantation experiments
using chromosomally marked cells identi-
fied unique patterns of stem cell regener-
ation and also demonstrated conclusively
that lymphoid and myeloid cells could be
derived from a single cell (Abramson
et al., 1977). Since then, technological
advances have allowed more precise
interrogation of individual hematopoietic
stem and progenitor cells (HSPCs). In
the mouse, concepts of stem cell hetero-
geneity are now well established (Copley
et al., 2012), and the hematopoietic hier-
archy has been found to be more compli-
cated than originally thought (Kawamoto
and Katsura, 2009). Recent studies using
human cells xenotransplanted into immu-
nodeficient mice have revealed similar-
ities in human hematopoiesis (Doulatov
et al., 2010; Go¨rgens et al., 2013). How-
ever, differences in niche components,
cytokines, body temperature, life span,
and body size place artificial constraints
and demands onto primate hematopoi-
etic cells engrafted into murine hosts.
Thus, uncertainty remains as to the appli-
cability of the xenotransplant system to
inform regarding primate hematopoietic
biology in the setting of transplantation.
In this issue of Cell Stem Cell, two
papers report tracking thousands of
individual marked HSPCs in nonhuman
primates. The first paper (Kim et al.,
2014) tracked unique vector integration
sites to measure short- and long-term
clonal output of HSPCs in several
autologously transplanted macaques forup to 12 years. The second paper (Wu
et al., 2014) used a lentiviral barcoding
approach to track the clonal origins of
multiple differentiated cell types pro-
duced in the first 1–9 months post-
transplantation in similarly transplanted
macaques. These two complementary
studies provide the first data set of this
type in primates, providing valuable clonal
contribution and lineage specification
data for autologously transplanted pri-
mate HSPCs.
The long-term clonal analysis reported
by the Chen group (Kim et al., 2014) re-
vealed an initial stage of clonal fluctuation
for the first 6–12 months posttransplan-
tation, after which clonal contributions
largely stabilized, with waves of clones
expanding and contracting over a longer
period of time. The observation that clonal
stability was not observed until at least
1 year posttransplant indicates that, in
this setting, the fluctuations seen early
after transplantation likely reflect behav-
iors of progenitors rather than stem cells.
Most long-term clones, defined as those
persisting for 3–10 years, were undetect-
able at 2–4 months and were only
minor contributors of blood cells until
7–13 months posttransplantation, after
which they became the primary source
of circulating blood cells. Within the
long-term HSC clones, the authors ob-
served myeloid-biased, lymphoid-biased,
and balanced lineage outputs, with the
balanced HSCs becoming the predomi-
nant source of hematopoietic recon-
stitution over the longterm. Importantly,
the authors also compared the clones
observed in CD34+ HSPCs isolated from
the bone marrow several years posttrans-Cell Stem Ceplant with those observed in the blood at
a similar time point, and found high over-
lap with the balanced andmyeloid-biased
clones, but a lower overlap with the
lymphoid-biased clones. This suggests
that at least some of the lymphoid-biased
clones present in peripheral blood were
not a result of active hematopoiesis within
the bone marrow, but instead were a
remnant of long-lived lymphoid cells
from an exhausted clone.
In contrast, the report by the Dunbar
group (Wu et al., 2014) interrogates a rela-
tively short period of time posttransplan-
tation (4.5, 6.5, and 9.5 months in three
transplanted animals). This encompasses
the time period classified by Kim et al.
as predominantly/exclusively short-term
reconstitution (between 7 to 9 months)
and suggests that Wu et al. are analyzing
primarily hematopoietic progenitor cells,
since the downstream progeny of true
long-term HSCs would only have just
begun to appear at this time. Clonal
measurements of lineage output in the
period between 1 and 6 months post-
transplant indicated an initial wave of
unilineage progenitors, followed by suc-
cessive waves of granulocyte/monocyte
(termed myeloid, M), myeloid/B cell
(M/B), and finally myeloid/B cell/T cell
(M/B/T) progenitors. Of interest, the barc-
odes seen in the myeloid and B cells at a
given time point seemed to correlate
better than those in T cells and B cells
alone, indicating output from M/B or
M/B/T progenitors, but not common
lymphoid (B/T) progenitors. This is consis-
tent with recent findings in vitro and in
immunodeficient mice (Doulatov et al.,
2010), and it is further evidence that all 14, April 3, 2014 ª2014 Elsevier Inc. 419
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myeloid lineage potential is likely not the
case in primates.
Perhaps the most striking observation
was the distinct clonal distribution of
natural killer (NK) cells. There are two
main NK cell subsets: the cytotoxic
CD56dimCD16+ NK cells, found primarily
in the blood, and the cytokine-producing
CD56brightCD16 NK cells, found primar-
ily in the lymphoid organs. The clonal
distribution of the CD56bright NK cells
generally correlated with M/B/T lineages.
However, the main population of NK
cells in the blood (CD56dimCD16+) did
not correlate with any other cell type,
suggesting that this NK subset had an
entirely different ontogeny. This is in
contrast to the generally accepted notion
that CD56brightCD16NK cells are precur-
sors of CD56dimCD16+ cells (Romagnani
et al., 2007). Furthermore, NK clonal dis-
tribution remained distinct from T and
B cell restricted clones, but correlated
instead with M/B and M/B/T clones.
This observation calls into question yet
another aspect of the traditional hemato-
poietic hierarchy model, which almost
invariably considers NK cells as progeny
of common lymphoid progenitors (CLPs).
The data here strongly suggests that
these two NK subsets have separate
origins and do not arise exclusively from
CLPs, at least not in a transplantation
setting.420 Cell Stem Cell 14, April 3, 2014 ª2014 ElIntegration-site-based methods of
clonal analysis have been used for more
than 2 decades, and as such many of
the technical challenges of this approach
have been discussed in detail. In contrast,
the barcoding method is relatively new
on the scene, and the technical caveats
are still being worked out. Initial design
and validation to determine size and
skewing of the barcode library is critical,
as is dealing with sequencing error and
setting appropriate thresholds to mini-
mize false-positives and false-negatives.
Both methods used here to some degree
encounter similar challenges of calibra-
tion and noise discrimination that cannot
be ignored (Bystrykh et al., 2012). Since
both Kim et al. and Wu et al. cotrans-
planted a large number of HSPCs per
recipient, inevitably many smaller clones
are at the edge of detection limits in the
blood. Due to the inherent challenges of
discriminating these small signals from
sequencing noise, the reliability of mea-
surement decreases dramatically pro-
portional to clone size. Therefore, the
frequencies of repopulating clones re-
ported here should be taken as general
estimates at best. Furthermore, it is
important to consider themajor difference
in the timing and duration of clonal
tracking (i.e., months versus years) when
comparing the data and conclusions of
the two papers. Although similar terminol-
ogy (such as short-term and long-term,sevier Inc.lineage-biased, and stability) is used in
both papers, they are not necessarily
referring to the same thing. In any case,
both of these studies provide exciting
new insights on the nature of hematopoi-
etic reconstitution in a clinically relevant
transplantation system.
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